the sankyo team-up is not relenza but was loosely called relenza mk2; it is now identified as LANI ( long action neuramidase inhibitor) the product is now in phase 1 trial and is own 50/50 by bta/sankyo
- Forums
- ASX - By Stock
- good angle on lawsuit
the sankyo team-up is not relenza but was loosely called relenza...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online